These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20025260)

  • 1. Strategies and limitations in dendrimeric immunogen synthesis. The influenza virus M2e epitope as a case study.
    Kowalczyk W; de la Torre BG; Andreu D
    Bioconjug Chem; 2010 Jan; 21(1):102-10. PubMed ID: 20025260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of multiple antigenic peptides (MAPs)-strategies and limitations.
    Kowalczyk W; Monsó M; de la Torre BG; Andreu D
    J Pept Sci; 2011 Apr; 17(4):247-51. PubMed ID: 21391284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
    Zou P; Liu W; Chen YH
    Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.
    Wang Y; Zhou L; Shi H; Xu H; Yao H; Xi XG; Toyoda T; Wang X; Wang T
    Biochem Biophys Res Commun; 2009 Jul; 385(1):118-22. PubMed ID: 19410554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of different presentation strategies for an HIV peptide immunogen.
    Cruz LJ; Iglesias E; Aguilar JC; González LJ; Reyes O; Albericio F; Andreu D
    Bioconjug Chem; 2004; 15(1):112-20. PubMed ID: 14733590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins.
    Liu W; Chen YH
    Eur J Immunol; 2005 Feb; 35(2):505-14. PubMed ID: 15627976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
    Wang R; Song A; Levin J; Dennis D; Zhang NJ; Yoshida H; Koriazova L; Madura L; Shapiro L; Matsumoto A; Yoshida H; Mikayama T; Kubo RT; Sarawar S; Cheroutre H; Kato S
    Antiviral Res; 2008 Nov; 80(2):168-77. PubMed ID: 18598723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
    Meshcheriakova IuA; El'darov MA; Migunov AI; Stepanova LA; Repko IA; Kiselev OI; Lomonosov DP; Skriabin KG
    Mol Biol (Mosk); 2009; 43(4):741-50. PubMed ID: 19807038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants.
    Nemchinov LG; Natilla A
    Protein Expr Purif; 2007 Dec; 56(2):153-9. PubMed ID: 17644356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse thioether ligation route to multimeric peptide antigens.
    Monsó M; Kowalczyk W; Andreu D; de la Torre BG
    Org Biomol Chem; 2012 Apr; 10(15):3116-21. PubMed ID: 22407078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully synthetic immunogens. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties.
    Wünsch E; Moroder L; Hübener G; Musiol HJ; Von Grünigen R; Göhring W; Scharf R; Schneider CH
    Int J Pept Protein Res; 1991 Feb; 37(2):90-102. PubMed ID: 1708369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
    Wu F; Yuan XY; Huang WS; Chen YH
    Vaccine; 2009 Oct; 27(43):6095-101. PubMed ID: 19056447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
    Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
    Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity.
    Liu W; Peng Z; Liu Z; Lu Y; Ding J; Chen YH
    Vaccine; 2004 Dec; 23(3):366-71. PubMed ID: 15530682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic approaches to multivalent lipopeptide dendrimers containing cyclic disulfide epitopes of foot-and-mouth disease virus.
    De Oliveira E; Villén J; Giralt E; Andreu D
    Bioconjug Chem; 2003; 14(1):144-52. PubMed ID: 12526703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
    Eliasson DG; El Bakkouri K; Schön K; Ramne A; Festjens E; Löwenadler B; Fiers W; Saelens X; Lycke N
    Vaccine; 2008 Feb; 26(9):1243-52. PubMed ID: 18243429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.